Good news!
"The US Food and Drug Administration has cleared biotech firm United Therapeutics to begin the first clinical trial transplanting genetically modified pig organs into humans. The company, which has engineered pigs with ten genetic edits that help the organs evade the human immune system, has already transplanted several kidneys and hearts into individuals on a case-by-case basis. Its new trial aims to transplant pig kidneys into up to 50 people with end-stage renal disease. United Therapeutics’ competitor, eGenesis, plans to ask the FDA to approve another clinical trial using pig organs later this year."
"The first clinical trial testing whether pig kidneys can be safely transplanted into living people has been approved by the US Food and Drug Administration (FDA). As part of the trial, which will begin later this year, kidneys from genetically modified pigs will be transplanted into people with chronic kidney disease whose organs no longer function independently. ..."
The science behind the first pig-organ transplant trial in humans "The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively."
Surgeons at Massachusetts General Hospital in Boston transplanted a modified pig kidney into a living person for the first time in 2024.
No comments:
Post a Comment